Back
NexPoint Residential Trust Vs. Neurogene Industry Stock Comparison
Sell
30
NXRT
NexPoint Residential Trust
Last Price:
42.32
Seasonality Move:
7.02%
Buy
75
NGNE
Neurogene
Last Price:
64.32
Seasonality Move:
58.98%
Sell
30
NexPoint Residential Trust (NXRT)
is a Sell
Is NexPoint Residential Trust a Buy, Sell or Hold?
- The current NexPoint Residential Trust [NXRT] share price is $41.19. The Score for NXRT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NXRT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NXRT Stock Price Chart
What is NexPoint Residential Trust's stock price today?
-
The NexPoint Residential Trust share price today is $41.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NXRT is experiencing slight buying pressure.
NGNE Stock Price Chart
NXRT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 33.46 | Sell |
| Chaikin Money Flow: | 9381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.04 - 44.08) | Sell |
| Bollinger Bands (100): | (39.98 - 45.52) | Sell |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 75.97 | Buy |
| Chaikin Money Flow: | 176225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.28 - 53.36) | Buy |
| Bollinger Bands (100): | (34.64 - 46.72) | Buy |
NXRT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.43 | Sell |
| 20-day SMA: | 43.02 | Sell |
| 50-day SMA: | 44.36 | Sell |
| 200-day SMA: | 37.68 | Buy |
| 8-day EMA: | 42.17 | Sell |
| 20-day EMA: | 42.95 | Sell |
| 50-day EMA: | 43.35 | Sell |
| 200-day EMA: | 40.06 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.43 | Buy |
| 20-day SMA: | 49.56 | Buy |
| 50-day SMA: | 43.32 | Buy |
| 200-day SMA: | 37.93 | Buy |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 48.54 | Buy |
| 50-day EMA: | 44.96 | Buy |
| 200-day EMA: | 36.96 | Buy |
NexPoint Residential Trust Earnings Growth & NXRT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $2.10 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
NexPoint Residential Trust Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||